The New York Times

The Promise of Ecstasy for PTSD

WAR VETERANS, VICTIMS OF ABUSE AND OTHERS DESERVE A CHANCE TO USE THIS DRUG TO HEAL.

In July, the Food and Drug Administration took the important step of approving two final-phase clinical trials to determine whether a party drug that has long been on the Drug Enforcement Administration’s Schedule I list of banned substances could be used to treat a psychiatric condition that afflicts millions. The drug is MDMA, a psychedelic commonly known as Ecstasy, previously deemed to have “no currently accepted medical use.” The trials aim to determine whether the drug is,

This article originally appeared in .

You're reading a preview, sign up to read more.

More from The New York Times

The New York Times5 min readSociety
Why the Oscars, Emmys and Tonys Are Not Ready for They and Them
Sam Smith, the British crooner with a voice often described as heaven sent, announced in September that “my pronouns are they/them.” Days later, the Brit Awards, which had nominated Smith for top male artist earlier in the year, said the categories w
The New York Times4 min read
Exercise Advice for Surviving Cancer, and Maybe Avoiding It
New guidelines say exercise may help cancer patients live longer, or help you avoid getting cancer in the first place.
The New York Times5 min readPolitics
How Deutsche Bank Hired Its Way to the Top in China
Numerous corporations have been fined in recent years for misconduct. The question is whether the large penalties deter bad behavior. Corporations cannot seem to avoid misconduct. Ford Motor recently announced a criminal probe of its emissions and fu